New research indicates that individuals who come off blockbuster GLP-1 drugs like Mounjaro or Wegovy can put back on reduced body mass at a significantly accelerated pace than those who halt conventional diet and exercise programs.
Findings released in a prominent health publication points out that while overweight individuals often shed a large proportion of their body weight while using the jabs, the mass comes back at an average rate of 0.8 kg per month after stopping.
"Individuals purchasing such treatments must be cognizant of the risk of fast rebound weight gain when the therapy is stopped," warns lead investigator Dr. Susan Jebb.
This pace of recovery suggests a reversion to pre-treatment mass in about 18 months.
Analyzing Approaches
The research, which examined dozens of studies involving over 9,000 of patients, compared the outcomes of these new drugs with conventional dieting.
Scientists emphasize that individuals who lose weight through dieting usually see a more gradual weight regain—around 100 grams monthly—once they finish.
Understanding the Rapid Regain
Nutrition scientists suggest the mechanism of the jabs accounts for the accelerated regain.
These medications imitate a natural hormone called glucagon-like peptide-1, which helps regulate hunger.
"Sustained high doses of the hormone concentrations several times higher than the body's typical production might result in the body to produce less of its endogenous GLP-1, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a dietetics expert.
"Stopping of this GLP-1 'fix' leads to hunger is unsuppressed, making binge eating much more probable."
A Chronic Condition?
Medical guidelines recommend the injections for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.
A number of clinicians contend that, considering the likelihood of weight regain, the treatment should be considered life-long.
This opinion is supported by drug manufacturers, who note that the findings "underscore the persistent character of obesity," comparing it to managing conditions like diabetes.
User Testimonies
People who have come off the jabs explain a intense resurgence of appetite.
"It was like a switch activating and you become ravenous," described one woman.
This challenge is exacerbated if patients have not adopted lasting lifestyle or habit changes during treatment.
Significant Interest
Recent estimates suggest that millions of people in the UK have used weight-loss jabs in the last 12 months, with interest remaining high.
- Adoption is greater among women compared to males.
- The 40s and 50s demographic shows the highest level of interest.
- Many obtain the drugs through private healthcare rather than public health services.
Finally, clinicians caution that while the jabs are powerful agents for weight loss, they are not a magic cure and lasting health benefits relies on combined lifestyle support.
